Neurogenic bladder is a condition in which bladder function is impaired due to upper or lower motor neuron lesions. Spinal cord injury, multiple sclerosis, spina bifida, diabetic neuropathy, and cerebrovascular diseases are the most common causes. Depending on the level of the lesion, detrusor overactivity (upper motor neuron — spastic bladder) or detrusor areflexia (lower motor neuron — flaccid bladder) develops. In upper motor neuron lesions, the bladder wall thickens, trabeculation and diverticula form; bladder capacity decreases and high intravesical pressure may cause vesicoureteral reflux. In lower motor neuron lesions, the bladder distends, the wall is thin, and large residual volume remains. Chronic neurogenic bladder can lead to upper urinary tract damage (hydronephrosis, reflux nephropathy), recurrent infections, and rarely bladder carcinoma (especially squamous cell carcinoma with long-term catheter use). Imaging evaluates bladder wall thickening, trabeculation, diverticula, increased or decreased capacity, and accompanying upper urinary tract changes.
Age Range
20-80
Peak Age
50
Gender
Equal
Prevalence
Common
The fundamental pathophysiology of neurogenic bladder is disruption of neuronal coordination between the bladder detrusor muscle and urethral sphincter. The normal micturition reflex arc depends on coordination between the sacral micturition center (S2-S4) and the pontine micturition center. In upper motor neuron lesions (suprasacral — spinal cord injury, MS), the pontine-sacral connection is interrupted; detrusor overactivity and detrusor-sphincter dyssynergia develop. High intravesical pressure leads to detrusor hypertrophy in the bladder wall — this is reflected as wall thickening and trabeculation on imaging. Chronic high pressure causes connective tissue infiltration between muscle fibers in the bladder wall, eventually leading to loss of wall compliance. Mucosal herniation between trabeculae leads to diverticulum formation — these areas appear as outpouchings from the bladder contour on CT and MRI. In lower motor neuron lesions (cauda equina, peripheral neuropathy), detrusor contractility is lost; the bladder distends and becomes thin-walled — seen as a large-capacity, thin-walled bladder on US and CT. Chronic retention and stasis predispose to recurrent UTIs; infection and chronic inflammation can lead to fibrosis and calcification in the bladder wall.
In upper motor neuron type neurogenic bladder, the bladder assumes a shape tapering upward with irregular contour and trabeculated appearance — this appearance is called 'Christmas tree' bladder. Due to detrusor-sphincter dyssynergia, there is prominent thickening at the bladder fundus with lateral bulging while the bladder neck and trigone region remain narrow. This shape is best seen on cystourethrography and on delayed phase CT with opacified urine.
Diffuse bladder wall thickening (>5 mm in distended bladder) and trabeculation are seen in the delayed phase. Trabeculation appears as mucosal indentations between hypertrophic detrusor muscle bundles. The bladder contour becomes irregular and lobulated. Wall thickening is symmetric and diffuse — focal thickening should raise suspicion for tumor. In the delayed phase, the contrast difference between opacified urine in the lumen and the thickened wall is clearly evaluated.
Report Sentence
Diffuse bladder wall thickening and trabeculation are observed, consistent with upper motor neuron type neurogenic bladder; no focal mass lesion is identified.
Multiple diverticulum formations extending outward from the bladder contour — mucosal herniation due to high intravesical pressure. Diverticula fill with opacified urine in the delayed phase and are isodense with the bladder lumen. Size varies from a few mm to several cm. Diverticula open to the bladder lumen through a narrow neck. Risk of stasis and infection within diverticula is increased; rarely, intradiverticular carcinoma may develop.
Report Sentence
Multiple diverticula extending outward from the bladder contour are observed, consistent with neurogenic bladder changes due to high intravesical pressure.
Prominent trabeculation pattern of the bladder wall on T2-weighted images — hypertrophic detrusor muscle bundles appear as low signal (hypointense) bands on T2, while mucosal invaginations between them appear as areas filled with high signal (hyperintense) urine. This alternating pattern is the signature MRI finding of neurogenic bladder. Bladder wall thickness is best evaluated on T2 sagittal and coronal images. In flaccid bladder, the wall is thin and trabeculation is absent; bladder capacity is increased.
Report Sentence
Prominent trabeculation pattern of the bladder wall is observed on T2-weighted images, suggesting neurogenic bladder changes consistent with detrusor hypertrophy.
No significant diffusion restriction is expected in the bladder wall in neurogenic bladder on diffusion-weighted imaging — this is a critical finding for differentiation from malignant wall thickening (urothelial carcinoma). Thickened detrusor muscle shows low signal on DWI and normal-to-high values on ADC map. Urothelial carcinoma shows prominent diffusion restriction (high signal on DWI, low ADC). Focal diffusion restriction may be seen in the presence of concurrent infection or abscess.
Report Sentence
No significant diffusion restriction is observed in the thickened portions of the bladder wall on DWI, with no findings favoring malignant wall involvement.
Diffuse, homogeneous enhancement of the thickened bladder wall is observed on contrast-enhanced MRI. Enhancement may be more prominent than normal due to increased vascularity from muscle hypertrophy. Enhancement pattern is diffuse and symmetric — focal or asymmetric enhancement should raise suspicion for tumor. Wall-lumen differentiation is clearly evaluated on delayed contrast sequences.
Report Sentence
Diffuse homogeneous enhancement of the thickened bladder wall is observed on contrast-enhanced images with no focal mass enhancement identified.
Irregular wall thickening and trabeculation pattern of the bladder wall on B-mode ultrasonography — the inner surface of the wall appears lobulated and irregular. Normal bladder wall is <3 mm in distended bladder, while it can reach >5 mm in neurogenic bladder. Trabeculae appear as hyperechoic bands, with anechoic urine-filled areas between them. Diverticula appear as anechoic sacs extending outward from the bladder contour. Post-void residual volume measurement should be performed — >100 mL is considered abnormal.
Report Sentence
Diffuse bladder wall thickening (__ mm) and trabeculation are observed on ultrasonography with increased post-void residual volume (_ mL); findings are consistent with neurogenic bladder changes.
Upper urinary tract complications of neurogenic bladder are evaluated on CT: bilateral ureterohydronephrosis (ureteral dilation and renal pelvic distension), renal parenchymal thinning (chronic obstructive changes), cortical scarring (reflux nephropathy), distal ureteral dilation and tortuosity. Ureteral dilation due to vesicoureteral reflux is typically more prominent in the lower third. Concurrent renal or bladder stones are commonly seen.
Report Sentence
Bilateral ureterohydronephrosis and renal parenchymal thinning accompanying neurogenic bladder changes are observed, suggesting upper urinary tract involvement due to chronic high intravesical pressure.
Criteria
Suprasacral lesion (spinal cord injury, MS, cerebrovascular event). Detrusor overactivity and detrusor-sphincter dyssynergia. Small-capacity, high-pressure bladder.
Distinct Features
Prominent wall thickening and trabeculation, multiple diverticula, Christmas tree bladder shape, small bladder capacity (<150 mL), high risk of bilateral hydronephrosis. High intravesical pressure threatens upper urinary tract.
Criteria
Sacral or infra-sacral lesion (cauda equina syndrome, peripheral neuropathy, diabetic cystopathy). Detrusor areflexia. Large-capacity, low-pressure bladder.
Distinct Features
Thin bladder wall, minimal or absent trabeculation, greatly increased bladder capacity (>500-1000 mL), high post-void residual volume, overflow incontinence. Wall compliance is preserved but emptying function is lost.
Criteria
Combined lesion containing both upper and lower motor neuron components (multiple sclerosis, spinal cord tumor, chronic disc herniation). Variable detrusor and sphincter behavior.
Distinct Features
Coexistence of both spastic and flaccid features on imaging — partially thickened wall with increased capacity. Urodynamic study is the gold standard for diagnosis.
Distinguishing Feature
Cystitis can cause diffuse wall thickening but trabeculation and diverticulum formation are not expected. Mucosal edema and enhancement are more prominent in cystitis. Clinically presents with dysuria, frequency, and fever. No neurological disease history.
Distinguishing Feature
Urothelial carcinoma presents as focal asymmetric wall thickening or polypoid mass; in neurogenic bladder, thickening is diffuse and symmetric. Urothelial carcinoma shows prominent diffusion restriction on DWI; neurogenic bladder shows no diffusion restriction. Early enhancement and stalk sign are seen in urothelial carcinoma.
Distinguishing Feature
Radiation cystitis requires history of pelvic radiotherapy. Wall thickening may be diffuse but is limited to the radiation field. Bladder capacity is decreased. Calcification is more common. Trabeculation and diverticulum formation are not expected; wall is fibrotic and rigid.
Distinguishing Feature
Isolated bladder diverticulum usually develops due to distal ureteral obstruction or BPH; diverticula in neurogenic bladder are multiple and accompanied by trabeculation. In isolated diverticulum, bladder wall is of normal thickness and there is no neurological history.
Urgency
routineManagement
medicalBiopsy
Not NeededFollow-up
6-monthThe main goals in neurogenic bladder management are protecting the upper urinary tract, achieving social continence, and preventing complications. Treatment options include: clean intermittent catheterization (CIC), anticholinergic medications (oxybutynin, tolterodine), botulinum toxin intradetrusor injection, surgical augmentation cystoplasty, and supravesical diversion. Regular upper urinary tract follow-up (hydronephrosis assessment with US) and urodynamic study are required. With long-term catheter use (>10 years), risk of squamous cell carcinoma is increased — annual cystoscopy is recommended.
Neurogenic bladder can lead to recurrent urinary infections, vesicoureteral reflux, hydronephrosis, and renal failure. Long-standing neurogenic bladder increases the risk of bladder carcinoma (especially in SCI). Treatment includes clean intermittent catheterization, anticholinergic medications, and surgery (augmentation cystoplasty) if needed. Regular upper urinary tract surveillance is critical.